Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status

Alexander A L Jorge, Thomas Edouard, Mohamad Maghnie, Alberto Pietropoli, Nicky Kelepouris, Alicia Romano, Martin Zenker, Reiko Horikawa

Open source

DOI
10.1530/ec-21-0615
Published
2022-04-01
Container
Endocrine Connections
Publisher
Bioscientifica
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1530/ec-21-0615,
  title = {Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status},
  author = {Alexander A L Jorge and Thomas Edouard and Mohamad Maghnie and Alberto Pietropoli and Nicky Kelepouris and Alicia Romano and Martin Zenker and Reiko Horikawa},
  year = {2022},
  journal = {Endocrine Connections},
  doi = {10.1530/ec-21-0615},
  url = {https://doi.org/10.1530/ec-21-0615}
}

RIS

TY  - JOUR
TI  - Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
AU  - Alexander A L Jorge
AU  - Thomas Edouard
AU  - Mohamad Maghnie
AU  - Alberto Pietropoli
AU  - Nicky Kelepouris
AU  - Alicia Romano
AU  - Martin Zenker
AU  - Reiko Horikawa
PY  - 2022
JO  - Endocrine Connections
DO  - 10.1530/ec-21-0615
UR  - https://doi.org/10.1530/ec-21-0615
ER  - 

APA

Jorge, A. A. L., Edouard, T., Maghnie, M., Pietropoli, A., Kelepouris, N., Romano, A., Zenker, M., & Horikawa, R. (2022). Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status. Endocrine Connections. https://doi.org/10.1530/ec-21-0615

Source records